American Optometric Association

Majcher discusses innovations in ocular imaging and the importance of educating patients on early warning signs of myopia to halt disease progression.

Thomas discusses emerging therapies, new technologies, and the reform needed to help these new developments reach the patients in need of them.

Landela’s research on an impoverished community in South Africa encourages clinicians to help similar populations get the care they need.

Nguyen spoke to the importance of being aware of heightened stress, anxiety, and depression due to myopia’s long-term treatment requirements.

Overexposure to mobile phones and similar devices can impact ocular and mental health; Roe suggests methods of managing screen time.

Lonsberry recommends alternative approaches to manage postoperative pain, balancing the need for relief against the risk of addiction and death.

Whitley speaks to the plethora of available biologics, the choice paralysis that can accompany the wide range of options, and the future of the industry.

Drs. Richman and Wartman discuss the benefits of using predictive and diagnostic AI, while cautioning about the implicit risks of overreliance on early, imperfect technology.

Attar discusses the medication pipeline, possible AI implementation, and the importance of making patients aware of clinical trials for rare genetic diseases.

Lang discusses his expectations and excitement for upcoming developments in the field and encourages clinicians to work together to better treat complex patients.

A worldwide increase in both near-work and screen usage has led to a spike in myopia rates; this study associates this with near exophoria caused by close reading.

Brimer sat down with HCPLive to discuss her presentation of a study analyzing the refill rates of PFHO and common alternative cyclosporine ophthalmic emulsion .05%.

A recent post hoc analysis of 2 pivotal phase 3 trials has determined the efficacy of acoltremon .003% in reducing ocular surface damage in dry eye disease.

Nearchou discusses the implications for early detection of specific learning disabilities and the potential for early intervention to provide equal access to education.

Based on recent data, artificial intelligence can improve patients’ awareness of their condition, as well as confidence in, and satisfaction with, their care.

Research has indicated a substantial increase in axial length, a contributing factor of myopia, in young adults who report regular mobile device usage.

Despite its availability as an over-the-counter medication, BTOS is frequently prescribed by clinicians for the treatment of ocular redness due to minor eye irritations.

This interim report of an ongoing study has indicated an overall positive impression of the INFUSE for Astigmatism contact lens among a 100-patient population.

A survey study has indicated a substantially positive perspective on UMFfA contact lenses, including reports on well-maintained vision, comfort, and ease of fitting.

Lifitegrast 5% led to improvements in OSDI, MMP-9, tear osmolarity, and a variety of other biomarkers and clinical signs of DED.